Clinical Care
Dr. Tomas S. Aleman, MD, provides exceptional clinical care for individuals with inherited retinal diseases. 
Backed by a dedicated team and state-of-the-art equipment, Dr. Aleman offers a comprehensive range of services including clinical and genetic diagnoses, second opinions, routine and specialized care.
Dr. Aleman is a board-certified ophthalmologist and a fellowship-trained medical retina and retinal degeneration specialist with a distinguished 30-year career in inherited retinal diseases. His expertise and commitment to patient care have earned him recognition as a leading authority in the field.
Dr. Aleman is available to see patients at three locations: the Scheie Eye Institute, the Perelman Center for Advanced Medicine, and the Children's Hospital of Philadelphia.
The CHRD team and Dr. Aleman have published over 400 scientific articles leading to key advances in the understanding and potential treatment of inherited retinal diseases.
There are several clinical trials that are either currently ongoing or soon to be starting to enroll patients:
|
Indication |
Phase |
Treatment |
More information at ClinicalTrials.gov |
|
LCA1 / GUCY2D |
1/2 |
Subretinal gene augmentation |
|
|
LCA5 / Lebercilin |
1/2 |
Subretinal gene augmentation |
|
|
LCA10 / CEP290 |
1/2 |
Subretinal gene editing |
|
|
RP |
3 |
Oral N-acetylcysteine |
Inherited retinal diseases evaluated include:
|
Retinitis pigmentosa |
|
Stargardt disease |
|
Best disease |
|
Leber congenital amaurosis |
|
Cone and cone rod dystrophies |
|
Blue cone monochromatism |
|
Achromatopsia |
|
Macular dystrophies |
|
Usher syndrome |
|
Bardet Biedl syndrome |
|
Syndromic retinitis pigmentosa |
|
Mitochondrial retinopathies |
|
Choroideremia |
|
Gyrate atrophy |
|
Late-onset retinal degeneration |